Social Contact-Based Brief Video Interventions To Reduce Stigma and ImproVe Engagement in HIV Prevention and Care and Mental Health Care for Youth Living With and Vulnerable to HIV (STRIVE)
| Registry | NCT07851077, acronym STRIVE |
|---|
| Status | Not yet recruiting |
|---|
| Phase | Not applicable |
|---|
| Study type | Interventional; randomized, parallel, masking: single, screening |
|---|
| Enrollment | 3900 (Estimated) |
|---|
| Sponsor | City University of New York, School of Public Health (Other); collaborators: Columbia University |
|---|
| Conditions | HIV, Mental Health |
|---|
| Interventions | Brief Videos for HIV Stigma (Behavioral) |
|---|
| Dates | start 2028-01-01 (estimated), primary completion 2028-07-01 (estimated), completion 2031-07-01 (estimated), first posted 2026-10-01, last updated 2026-10-01 |
|---|
Related Papers Related Patents Related Grants Related Experts
All trials for HIV All trials for Mental Health All trials of Brief Videos for HIV Stigma
-Summary
HIV stigma, poverty, and racism contribute to high rates of mental health problems and impede treatment for young sexually minoritized men living with and vulnerable to HIV. Intersectional interventions can reduce barriers and promote access to health services, thus preventing poor health outcomes including HIV transmission related behaviors. The STRIVE intervention will address public and internalized HIV stigma and thus reduce the duration of untreated HIV and mental health problems among young men living with or vulnerable to HIV.
Expand all sections · Collapse all
+Arms and interventions
| Arm | Type | Interventions | Description |
|---|
| intervention group (BVHS) | Experimental | Behavioral: Brief Videos for HIV Stigma | Participants will receive Brief Videos for HIV Stigma (BVHS) |
| Control | No intervention | | Participants will receive videos without BVHS |
- Brief Videos for HIV Stigma (Behavioral): Intersectionally-tailored brief videos to reduce public and internalized HIV stigma (BVHS)
+Outcome measures
Primary outcomes
- Percentage of participants who attend an HIV care visit within 30 days after enrollment [Within 30 days after enrollment]: Linkage to HIV care is defined as completion of at least one visit with a STRIVE telehealth navigator, within 30 days after enrollment. Visit attendance will be recorded as Yes or No documented by a STRIVE telehealth navigator. The outcome will be reported as the percentage of participants who meet this criterion.
- Percentage of participants who are linked to HIV prevention within 30 days after enrollment [Within 30 days after enrollment]: Linkage to HIV prevention is defined as completion of at least one visit with a STRIVE telehealth navigator, within 30 days after enrollment. Visit attendance will be recorded as Yes or No documented by a STRIVE telehealth navigator. The outcome will be reported as the percentage of participants who meet this criterion.
Secondary outcomes
- Percentage of participants who are linked to mental health care [Within 30 days after enrollment]: Linkage to mental health care is defined as completion of at least one visit with a STRIVE telehealth navigator, within 30 days after enrollment. Visit attendance will be recorded as Yes or No documented by a STRIVE telehealth navigator. The outcome will be reported as the percentage of participants who meet this criterion.
- brief Berger HIV Stigma scale [Baseline, immediate post, 30 days post]: The 12-item Brief Berger HIV Stigma Scale is a shortened, validated version of the original 40-item Berger HIV Stigma Scale designed to measure perceived, anticipated, and internalized stigma among people living with HIV (PLWH) while reducing respondent burden. Cumulative scores range from 12 to 48, with higher scores reflecting higher levels of perceived stigma.
- Attitudes Toward Seeking Professional Psychological Help Scale-Short Form [Baseline, immediately post, 30 days post]: A 10-item questionnaire used to measure a person's general openness and perspective on getting mental health therapy. Total scores generally range from 0 to 30, with higher scores showing a more positive attitude toward going to therapy.
Other outcomes
- Patient Health Questionnaire-9 [baseline]: A 9-item self-administered tool used to screen, diagnose, monitor, and measure the severity of depression.
Each of the 9 questions is scored from 0 (not at all) to 3 (nearly every day). Total Score Range: 0 to 27
.Score Interpretation 0-4: Minimal or no depression. 5-9: Mild depression. 10-14: Moderate depression. 15-19: Moderately severe depression. 20-27: Severe depression
- Generalized Anxiety Disorder-7 [baseline]: A short, 7-question self-report questionnaire used to screen for generalized anxiety disorder and measure symptom severity.
Each item is scored from 0 to 3:
0 = Not at all
1. = Several days
2. = More than half the days
3. = Nearly every day
Total Score:
0-4: Minimal anxiety 5-9: Mild anxiety (monitor symptoms) 10-14: Moderate anxiety (possible clinically significant condition) 15-21: Severe anxiety (active treatment likely warranted
- Posttraumatic stress disorder symptoms [baseline]: 8-item short-form version of the PTSD Checklist for DSM-5 (PCL-5), designed to measure post-traumatic stress disorder (PTSD) symptom severity.
- HIV care provider visit [30 days post]: Single yes/no survey item, CHP clinic confirmation
- HIV treatment provider visit [30 days post]: Single yes/no survey item, CHP clinic confirmation
- Mental Health care provider visit [30 days post]: Single yes/no survey item, CHP clinic confirmation
+Eligibility
Sex: All, ages: 18 Years to 30 Years, accepts healthy volunteers
Inclusion Criteria:
* YSMM from the New York area aged 18-30 who are either living with HIV or vulnerable to HIV.
Exclusion Criteria:
* N/A